Parallax Volatility Advisers, L.P. Genmab A/S Call Options Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$33.66 - $40.76 $3.58 Million - $4.33 Million	-106,300 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$33.07 - $38.68 $1.17 Million - $1.37 Million	35,500 Added 50.14%	106,300 $3.89 Million
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $1.42 Million - $2.4 Million	70,800 New	70,800 $2.4 Million

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.